![Ian Walters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Walters
Directeur Général chez
SalvaRx Ltd.
Profil
Ian B. Walters is the founder of SalvaRx Group Plc, which was founded in 2007.
He held the title of Chief Executive Officer at SalvaRx Group Plc in 2019.
Dr. Walters currently holds the position of Chief Executive Officer at SalvaRx Ltd. He is also the Chairman at Stimunity SAS, Director at iOx Therapeutics Ltd., and Director at Boko Therapeutics, Inc. In his former positions, Dr. Walters was the Chief Executive Officer at Portage Biotech, Inc. from 2016 to 2024.
He also held various roles at Bristol Myers Squibb Co., Millennium Pharmaceuticals, Inc., 3Legs Resources Plc, RIFT biotherapeutics, Inc., Enzo Biochem, Inc., Sorrento Therapeutics, Inc., Bristol-Myers Squibb Canada Co., and Intensity Therapeutics, Inc.Dr. Walters received a doctorate degree from Albert Einstein College of Medicine, Inc. in 1993.
He also holds an MBA from The Wharton School of the University of Pennsylvania, which he obtained in 2003.
Postes actifs de Ian Walters
| Sociétés | Poste | Début |
|---|---|---|
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Directeur/Membre du Conseil | 01/07/2015 |
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Président | - |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Directeur Général | - |
Anciens postes connus de Ian Walters
| Sociétés | Poste | Fin |
|---|---|---|
| ALPHA COMPUTE CORP | Directeur Général | 14/12/2024 |
| INTENSITY THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2023 |
| SALVARX GROUP PLC | Fondateur | 08/01/2019 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Designs, develops and wholesales pharmaceutical services | Directeur des opérations | 01/03/2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Directeur Technique/Scientifique/R&D | - |
Formation de Ian Walters
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Enzo Biochem, Inc.
 Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
3Legs Resources Plc
 3Legs Resources Plc Financial ConglomeratesFinance Invests in acquired companies within the technology sector | Finance |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Designs, develops and wholesales pharmaceutical services | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SalvaRx Ltd.
SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Health Technology |
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company that focuses on immune-oncology & invests in novel cancer immune-therapies | Commercial Services |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibodies for use in oncology | Commercial Services |
Stimunity SAS
Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
